JP5159311B2 - オリゴペプチドおよびそれらの使用 - Google Patents

オリゴペプチドおよびそれらの使用 Download PDF

Info

Publication number
JP5159311B2
JP5159311B2 JP2007537158A JP2007537158A JP5159311B2 JP 5159311 B2 JP5159311 B2 JP 5159311B2 JP 2007537158 A JP2007537158 A JP 2007537158A JP 2007537158 A JP2007537158 A JP 2007537158A JP 5159311 B2 JP5159311 B2 JP 5159311B2
Authority
JP
Japan
Prior art keywords
amino acids
seq
acid
consecutive amino
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007537158A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008517009A5 (cg-RX-API-DMAC10.html
JP2008517009A (ja
Inventor
フィリップ・モゼ
ルイ・ダノー
ジル・ポーリー
ジャン−リュック・コンテ−オドノー
Original Assignee
ビーエーエスエフ、ビューティー、ケア、ソルーションズ、フランス、エスエーエス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ビーエーエスエフ、ビューティー、ケア、ソルーションズ、フランス、エスエーエス filed Critical ビーエーエスエフ、ビューティー、ケア、ソルーションズ、フランス、エスエーエス
Publication of JP2008517009A publication Critical patent/JP2008517009A/ja
Publication of JP2008517009A5 publication Critical patent/JP2008517009A5/ja
Application granted granted Critical
Publication of JP5159311B2 publication Critical patent/JP5159311B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
JP2007537158A 2004-10-18 2005-10-10 オリゴペプチドおよびそれらの使用 Expired - Lifetime JP5159311B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292475.3 2004-10-18
EP04292475 2004-10-18
PCT/EP2005/010893 WO2006042661A2 (en) 2004-10-18 2005-10-10 Oligopeptides and their use in cosmetics

Publications (3)

Publication Number Publication Date
JP2008517009A JP2008517009A (ja) 2008-05-22
JP2008517009A5 JP2008517009A5 (cg-RX-API-DMAC10.html) 2008-11-27
JP5159311B2 true JP5159311B2 (ja) 2013-03-06

Family

ID=34931464

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007537158A Expired - Lifetime JP5159311B2 (ja) 2004-10-18 2005-10-10 オリゴペプチドおよびそれらの使用

Country Status (6)

Country Link
US (2) US8044028B2 (cg-RX-API-DMAC10.html)
EP (1) EP1802655B1 (cg-RX-API-DMAC10.html)
JP (1) JP5159311B2 (cg-RX-API-DMAC10.html)
KR (1) KR101264441B1 (cg-RX-API-DMAC10.html)
ES (1) ES2426441T3 (cg-RX-API-DMAC10.html)
WO (1) WO2006042661A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1802655B1 (en) 2004-10-18 2013-07-24 BASF Beauty Care Solutions S.A.S. Oligopeptides and their use in cosmetics
PL2027152T3 (pl) * 2006-06-13 2012-04-30 Helix Biomedix Inc Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej
JP5789901B2 (ja) * 2008-05-29 2015-10-07 セラピューティック・ペプタイズ・インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃ Ｐｅｐｔｉｄｅｓ，Ｉｎｃ． 皮膚化粧用組成物におけるオリゴマーバイオサーファクタント
RU2411248C2 (ru) * 2008-11-13 2011-02-10 Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) Средство, обладающее антипсихотической активностью
WO2011036048A1 (en) 2009-09-24 2011-03-31 Unilever Nv Disinfecting agent comprising eugenol, terpineol and thymol
WO2011126054A1 (ja) * 2010-04-07 2011-10-13 国立大学法人京都大学 生理活性ペプチド
BR112013013085B1 (pt) 2010-12-07 2018-02-14 Unilever N.V. Composição de cuidados orais, enxaguante bucal, creme dental, dentífrico, método para desinfetar a cavidade oral e uso de uma composição
EA024551B1 (ru) 2011-11-03 2016-09-30 Юнилевер Н.В. Индивидуальная композиция для очищения
WO2013064633A1 (de) * 2011-11-04 2013-05-10 Amp-Therapeutics Gmbh Oncopeltus-peptidderivate als antimikrobielle peptide
FR3012811B1 (fr) * 2013-11-05 2015-12-25 Basf Beauty Care Solutions France Sas Oligopeptides et leurs utilisations
KR101851236B1 (ko) 2015-07-06 2018-04-24 김철군 동충하초 재배용 배지조성물 및 동충하초 재배방법
KR20190065916A (ko) 2017-12-04 2019-06-12 김철군 동충하초 재배용 배지조성물 및 동충하초의 재배방법
EP3906013A1 (en) 2019-01-02 2021-11-10 The Procter & Gamble Company Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract
KR102192471B1 (ko) * 2019-10-18 2020-12-17 주식회사 인코스팜 탈모 완화 및 모발 성장을 촉진시키는 펩타이드 및 이를 포함하는 화장료 조성물
KR102952819B1 (ko) * 2022-11-11 2026-04-16 웰펩 주식회사 피부세포 재생 효과가 우수한 펩타이드 및 이를 포함하는 피부세포 재생 촉진용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU68901A1 (cg-RX-API-DMAC10.html) 1973-11-30 1975-08-20
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
US6713605B1 (en) 1996-04-10 2004-03-30 Kansas State University Research Foundation Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes
US5830993A (en) 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
DE19756377A1 (de) 1997-12-18 1999-06-24 Beiersdorf Ag Verwendung von C¶1¶¶8¶-¶3¶¶8¶-Alkylhydroxystearoylstearat zur Verstärkung der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen
US6231768B1 (en) 1999-01-19 2001-05-15 Nalco Chemical Company Rheology modification of settled solids in mineral processing
FR2788777B1 (fr) 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
CA2368638A1 (en) * 1999-03-26 2000-10-05 Beth Israel Deaconess Medical Center Method for pr-39 peptide regulated stimulation of angiogenesis
CA2388868A1 (en) 1999-10-25 2001-05-03 Beth Israel Deaconess Medical Center Method for pr-39 peptide regulated stimulation of angiogenesis
AU2599001A (en) 1999-12-29 2001-07-09 Beth Israel Deaconess Medical Center Method for pr-39 peptide mediated selective inhibition of ikappabalpha degradation
ATE510852T1 (de) * 2001-10-30 2011-06-15 Dsm Ip Assets Bv Dermopharmazeutisch und kosmetisch wirksame oligopeptide
WO2003042387A1 (fr) * 2001-11-13 2003-05-22 Keio University Nouvelles proteines associees a la keratine des poils
FR2836042B1 (fr) * 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
CA2501645A1 (en) * 2002-10-10 2004-04-22 Verenium Corporation Proteases, nucleic acids encoding them and methods for making and using them
EP1802655B1 (en) 2004-10-18 2013-07-24 BASF Beauty Care Solutions S.A.S. Oligopeptides and their use in cosmetics

Also Published As

Publication number Publication date
US8044028B2 (en) 2011-10-25
EP1802655B1 (en) 2013-07-24
JP2008517009A (ja) 2008-05-22
ES2426441T3 (es) 2013-10-23
KR101264441B1 (ko) 2013-05-14
KR20070065882A (ko) 2007-06-25
US20100137560A1 (en) 2010-06-03
EP1802655A2 (en) 2007-07-04
WO2006042661A3 (en) 2006-07-27
WO2006042661A2 (en) 2006-04-27
US20120172308A1 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
US20120172308A1 (en) Oligopeptides And Their Use In Cosmetics
US8697151B2 (en) Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
US8815814B2 (en) Cosmetic composition containing oligopeptides
US8399415B2 (en) Oligopeptides and cosmetic compositions containing the oligopeptides
CN107847411A (zh) 含有香紫苏内酯的化妆品组合物
US20040028697A1 (en) Method for protecting the skin from aging
JP2003524650A (ja) 植物抽出物を含有する化粧品製剤
US20030068364A1 (en) Pro-liposomal encapsulated preparations (iv)
JP5324781B2 (ja) Ｐｔｈ断片含有化粧品
JP2003531844A (ja) 植物Ａｒｇａｎｉａｓｐｉｎｏｓａの抽出物を含有する化粧品製剤および／または医薬製剤
WO2015067525A1 (fr) Oligopeptides et leurs utilisations

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081009

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081009

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110510

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110809

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120313

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120611

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120731

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20120802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121010

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20121101

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121120

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121211

R150 Certificate of patent or registration of utility model

Ref document number: 5159311

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151221

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term